Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Oramed Pharmaceuticals Inc. ORMP NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
69/100
4/7 Pass
SharesGrow Intrinsic Value
$37.98
+894.2%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Oramed Pharmaceuticals Inc. (ORMP), dont 40 achats et 6 ventes. Le total des achats d'initiés s'élève à $1.44K et le total des ventes d'initiés à $1.59M.

Les initiés notables ayant une activité récente comprennent Kidron Nadav, Kidron Miriam, Hexter Joshua. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ORMP

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-03-30 Kidron Nadav President and CEO Retenue Fiscale RSU 44,818 $3.31 $148.35K 3,422,243
2026-03-30 Kidron Miriam Chief Scientific Officer Retenue Fiscale RSU 435,084 $3.31 $1.44M 1,133,138
2026-03-17 Kidron Nadav President and CEO Attribution de RSU 167,005 - - 3,422,243
2026-03-17 Kidron Miriam Chief Scientific Officer Attribution de RSU 119,558 - - 1,568,222
2026-03-17 Hexter Joshua COO & Cbo Attribution de RSU 95,889 - - 1,160,384
2026-03-17 Gabay Avraham Chief Financial Officer Attribution de RSU 95,889 - - 745,145
2026-03-12 Kidron Nadav President and CEO Don (Donné) 100,000 - - 3,255,238
2026-01-22 Kidron Nadav President and CEO Exercice d'Options (Vente) 109,000 - - -
2026-01-22 Kidron Miriam Chief Scientific Officer Exercice d'Options (Vente) 19,000 - - -
2026-01-22 Hexter Joshua COO & Cbo Exercice d'Options (Vente) 19,000 - - -
2026-01-22 Gabay Avraham Chief Financial Officer Exercice d'Options (Vente) 19,000 - - -
2026-01-14 Kidron Miriam Chief Scientific Officer Don (Donné) 86,166 - - 1,343,498
2025-12-31 Gabay Avraham Chief Financial Officer Attribution de RSU 19,000 - - 19,000
2025-12-31 Aghion Daniel Director Attribution de RSU 30,000 $0.01 $360.00 107,191
2025-12-31 Kidron Nadav President and CEO Attribution de RSU 109,000 - - 109,000
2025-12-31 Kidron Miriam Chief Scientific Officer Attribution de RSU 19,000 - - 19,000
2025-12-31 Hexter Joshua COO & Cbo Attribution de RSU 19,000 - - 19,000
2025-12-31 Mayer Arie Director Attribution de RSU 30,000 $0.01 $360.00 163,109
2025-12-31 Shapiro Benjamin Director Attribution de RSU 30,000 $0.01 $360.00 119,720
2025-12-31 Reznick Yehuda Director Attribution de RSU 30,000 $0.01 $360.00 98,930
2025-06-05 Sank Leonard Director Attribution de RSU 30,000 - - 128,021
2025-06-05 Mayer Arie Director Attribution de RSU 30,000 - - 126,134
2025-06-05 Shapiro Benjamin Director Attribution de RSU 30,000 - - 85,070
2025-06-05 Aghion Daniel Director Attribution de RSU 30,000 - - 68,820
2025-06-05 Reznick Yehuda Director Attribution de RSU 30,000 - - 60,560
2025-02-11 Kidron Nadav President and CEO Attribution de RSU 141,000 - - 2,400,598
2025-02-11 Kidron Miriam Chief Scientific Officer Attribution de RSU 74,000 - - 1,074,666
2025-02-11 Hexter Joshua COO & Cbo Attribution de RSU 45,000 - - 751,333
2025-02-11 Gabay Avraham Chief Financial Officer Attribution de RSU 34,000 - - 392,040
2025-01-02 Kidron Nadav President and CEO Attribution de RSU 433,500 - - 2,259,598
2025-01-02 Kidron Miriam Chief Scientific Officer Attribution de RSU 207,000 - - 1,000,666
2025-01-02 Hexter Joshua COO & Cbo Attribution de RSU 194,500 - - 706,333
2025-01-02 Gabay Avraham Chief Financial Officer Attribution de RSU 188,000 - - 358,040
2024-11-07 Kidron Nadav President and CEO Attribution de RSU 45,000 - - 1,826,098
2024-11-07 Kidron Miriam Chief Scientific Officer Attribution de RSU 30,000 - - 793,666
2024-11-07 Hexter Joshua COO & Cbo Attribution de RSU 30,000 - - 511,833
2024-11-07 Gabay Avraham Chief Financial Officer Attribution de RSU 30,000 - - 170,040
2024-06-21 Gabay Avraham Chief Financial Officer Attribution de RSU 140,040 - - -
2024-06-18 Gabay Avraham Officer Inconnu - - - -
2024-06-06 Reznick Yehuda Director Attribution de RSU 760 - - 30,560
2024-04-17 Reznick Yehuda Director Attribution de RSU 29,800 - - 29,800
2024-04-01 Reznick Yehuda Director Inconnu - - - -
2024-01-30 Aghion Daniel Director Attribution de RSU 3,750 - - 38,820
2024-01-04 Kidron Nadav President and CEO Attribution de RSU 329,000 - - 1,781,098
2024-01-04 Kidron Miriam Chief Scientific Officer Attribution de RSU 295,500 - - 763,666
2024-01-04 Sank Leonard Director Attribution de RSU 30,000 - - 88,696
2024-01-04 Hexter Joshua COO & Cbo Attribution de RSU 180,500 - - 481,833
2024-01-04 Mayer Arie Director Attribution de RSU 30,000 - - 86,809
2024-01-04 Silberman David Chief Financial Officer Attribution de RSU 136,500 - - 366,500
2024-01-04 Rozov Yadin Director Attribution de RSU 30,000 - - 146,500
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message